AbbVie Takes Aim at Vertex Pharmaceuticals Incorporated [The Motley Fool]
Vertex Pharmaceuticals Incorporated (VRTX)
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.vrtx.com
Company Research
Source: The Motley Fool
Do Vertex investors need to worry about the company's share of the cystic fibrosis space? At the moment, treatment options for cystic fibrosis are limited to drugs marketed by Vertex Pharmaceuticals Inc. ( NASDAQ:VRTX ) , but a deep-pocketed drugmaker just took a big step toward entering the space. AbbVie, Inc. ( NYSE:ABBV ) recently acquired full control of a clinical-stage cystic fibrosis program from Galapagos N.V. ( NASDAQ:GLPG ) . Should Vertex investors be worried, now that the company's main challenger is a biopharma giant with nearly endless resources for developing competing treatments? Here's what you need to know. Image source: Getty Images. Reasons to stay calm Galapagos recently reported preliminary results from an early-stage trial with its cystic fibrosis (CF) candidates; they didn't make a strong impression. During part one of the Falcon study, the dual combination of GLPG2451 and GPLG2222 led to a forced expiration volume (FEV) im
Show less
Read more
Impact Snapshot
Event Time:
VRTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VRTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VRTX alerts
High impacting Vertex Pharmaceuticals Incorporated news events
Weekly update
A roundup of the hottest topics
VRTX
News
- 2 Fantastic Growth Stocks to Buy Right Now [Yahoo! Finance]Yahoo! Finance
- Walgreens expands specialty pharmacy with unit dedicated to cell and gene therapies [Seeking Alpha]Seeking Alpha
- Vertex (VRTX), TreeFrog Sign Deal for Diabetes Cell Therapies [Yahoo! Finance]Yahoo! Finance
- Vertex in-licenses cell therapy technology for diabetes candidates [Seeking Alpha]Seeking Alpha
- Global Vaccine Contract Manufacturing Market Trends Analysis Report 2024-2030: Capacity Expansion by Contract Manufacturers, & Vaccination Innovation and Robust Vaccine Pipeline Bolsters Growth [Yahoo! Finance]Yahoo! Finance
VRTX
Earnings
- 2/5/24 - Beat
VRTX
Sec Filings
- 4/17/24 - Form 4
- 4/16/24 - Form PX14A6G
- 4/11/24 - Form SC
- VRTX's page on the SEC website